InvestorsHub Logo
Followers 1
Posts 129
Boards Moderated 0
Alias Born 01/27/2011

Re: None

Monday, 01/07/2019 5:47:14 PM

Monday, January 07, 2019 5:47:14 PM

Post# of 309
AFMD: new Corporate Presentation (January 7, 2019)

source: https://www.affimed.com/wp-content/uploads/20190107_afmd_corp_pres__final.pdf

Upcoming Anticipated Milestones:

AFM13
• H1 2019: 12-month data for AFM13 + Keytruda®(pembrolizumab)
• H1 2019: Initiate registration study (monotherapy in TCL)
• H1 2019: Initiate combination study with cbNK cells in CD30+ lymphomas (IST)
• H1 2020: Interim data for monotherapy in TCL

AFM24
• Mid-2019: IND filing
• H2 2019: Initiate first-in-human study
• 2020: Clinical data
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AFMD News